Tigermed, a prominent Contract Research Organization (CRO) with a presence in both Shenzhen (SHE: 300347) and Hong Kong (HKG: 3347) stock exchanges, has forged a strategic partnership with the Beijing government. This collaboration is marked by the inauguration of the company’s North Headquarters in the capital city.
Under this partnership, Tigermed and the Beijing government will engage in profound dialogues and collaborations across a spectrum of areas. These include fostering technological innovation, enhancing government-enterprise cooperation, nurturing talent, advancing digital transformation initiatives, adopting Environmental, Social, and Governance (ESG) best practices, and expanding into international markets.
This alliance signifies a commitment to joint growth and the pursuit of excellence in the pharmaceutical and healthcare sectors, leveraging the strengths of both parties to drive forward-looking projects and strategies.- Flcube.com